Further, interestingly, in both our HER2-amplified preclinical models with different genetic backgrounds, tumor eradication was achieved even with 20 mg/kg N, which is half the recommended human equivalent dose of 240 mg/kg38. Here, ERBB2 is linked to neoplasm.